Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSFOMYCIN vs FOSTEMSAVIR TROMETHAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSFOMYCIN vs FOSTEMSAVIR TROMETHAMINE: Safety Overview

Metric FOSFOMYCIN FOSTEMSAVIR TROMETHAMINE
Total FAERS Reports 828 163
Deaths Reported 128 11
Death Rate 15.5% 6.7%
Hospitalizations 407 13
Average Patient Age 55.3 yrs 58.8 yrs
% Female Patients 57.3% 12.7%
FDA Approval Date Oct 22, 2025 Jul 2, 2020
Manufacturer Meitheal Pharmaceuticals Inc. ViiV Healthcare Company
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription